Clinician-Administered Dissociative States Scale (CADSS-1)

Bremner JD; Krystal JH; Putnam FW; Southwick SM; Marmar C; Mazure CM; Charney DS

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

  • Published in 1998
  • A shorter version without observer items is existing (CADSS)

Bremner JD; Krystal JH; Putnam FW; Southwick SM; Marmar C; Mazure CM; Charney DS

©2008 J.Douglas Bremner, M.D. Not for use without permission
To measure present-state dissociative symptoms
Therapeutic area
  • Mental Disorders
  • Behavior and Behavior Mechanisms
Therapeutic indication
  • Dissociative Disorders
  • Stress Disorders, Post-Traumatic
  • Depression
  • Schizophrenia
  • Panic Disorder
Type of Clinical Outcome Assessment (COA)
  • Composite
PRO and ClinRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Bremner JD, Krystal JH, Putnam FW. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress. 1998 Jan;11(1):125-36 (Full Text Article)

Bremner JD. The Clinician Administered Dissociative States Scale: Instructions for Administration. Emory University. 2014 Mar

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use


Bremner JD; Krystal JH; Putnam FW; Southwick SM; Marmar C; Mazure CM; Charney DS

J. Douglas Bremner, MD
12 Executive Park Dr NE, Rm 333
Atlanta GA 30329

J. Douglas Bremner's publications (PubMed)

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.


Original language(s)

  • English for the USA


The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us